Boston Scientific boosts chronic pain therapy portfolio with Nalu deal

新聞報導於1天前

撰寫摘要中...

您可能也對這些小見聞有興趣

Political deadlock and spending on dual crises leaves French finances in disarray

What will happen next in this topsy-turvy stock market? Choose your own Wall Street adventure!

Jamie Dimon Wants Everyone in the Office. Is a $3 Billion Building the Answer?

DA Davidson Maintains Buy Rating on Walmart (WMT) Following Partnership with OpenAI

CSX profit falls 22% as new CEO takes over but performance is expected to improve

World’s largest food company is cutting 16,000 jobs due partly to automation

Small mortgage loans: How they work and where to find them

Treasury Yields Fall in Week Marked by Worries About U.S. Banks

This AI Stock With A Difference Builds Bullish Base, Eyes Entry Amid 83% Rally

William Blair Upgrades nCino (NCNO) to Outperform

返回所有小見聞